Technologie medyczne
Firmy argentyńskie działające w jednym sektorze: technologie medyczne
Te Firmy argentyńskie działają w tym samym sektorze, technologie medyczne. Znajdziesz tu ich ceny, zmiany i inne statystyki, które pomogą Ci poznać jak najwięcej szczegółów. Lista zawiera akcje dla dowolnej strategii: giganty o dużej kapitalizacji, takie jak ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1, spółki o największych zyskach, takie jak MODERNA INC CEDEAR EACH 19 REP 1 ORD i nie tylko. Filtruj listę i w wygodny sposób sprawdzaj wyniki firm.
Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Ocena Analityków |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 712,95 T ARS | 14 775,000 ARS | −0,84% | 11,06 K | 0,93 | 118,34 | 124,85 ARS | +564,33% | 0,48% | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 712,95 T ARS | 13,800 USD | −3,16% | 1,23 K | 1,49 | 107,10 | 124,85 ARS | +178,70% | 0,48% | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 375,09 T ARS | 11 475,000 ARS | −0,86% | 13,7 K | 1,32 | 37,39 | 306,92 ARS | +257,75% | 1,39% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 375,09 T ARS | 1 340,000 ARS | 0,00% | 2 | 0,00 | — | — | — | — | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 375,09 T ARS | 10,800 USD | −0,92% | 6,25 K | 2,69 | 34,10 | 306,92 ARS | +50,08% | 1,39% | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 313,95 T ARS | 19 650,000 ARS | +2,75% | 1,82 K | 0,51 | 8,39 | 2 343,37 ARS | +183,01% | 1,79% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 313,95 T ARS | 18,300 USD | −0,81% | 84 | 0,41 | 7,57 | 2 343,37 ARS | +18,73% | 1,79% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 251,9 T ARS | 22 175,000 ARS | 0,00% | 2,37 K | 1,91 | 25,10 | 883,37 ARS | +899,22% | 1,56% | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 251,9 T ARS | 22,000 USD | +3,53% | 15 | 0,31 | 24,13 | 883,37 ARS | +319,19% | 1,56% | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 210,04 T ARS | 28 950,000 ARS | +0,70% | 612 | 3,88 | 3,34 | 8 672,72 ARS | +474,20% | 3,52% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 205,19 T ARS | 36 475,000 ARS | +2,60% | 5,35 K | 2,94 | 53,81 | 677,80 ARS | +291,99% | 1,57% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 205,19 T ARS | 34,600 USD | 0,00% | 10 | 0,60 | 49,46 | 677,80 ARS | +64,44% | 1,57% | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 205,07 T ARS | 32 750,000 ARS | +0,31% | 974 | 2,75 | 51,99 | 629,98 ARS | +270,79% | 0,95% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 205,07 T ARS | 31,000 USD | 0,00% | 20 | 0,77 | 47,68 | 629,98 ARS | +55,55% | 0,95% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 197,11 T ARS | 25 825,000 ARS | −0,67% | 38,11 K | 327,09 | 46,20 | 558,94 ARS | +251,94% | 0,15% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 195,92 T ARS | 6 900,000 ARS | 0,00% | 8 | 0,16 | 130,46 | 52,89 ARS | +386,62% | 0,00% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 171,03 T ARS | 5 070,000 ARS | +6,74% | 1,12 K | 13,02 | 1,00 | 5 080,23 ARS | +58,18% | 0,45% | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 158,96 T ARS | 10 900,000 ARS | +1,16% | 888 | 0,06 | 43,76 | 249,09 ARS | −19,94% | 2,25% | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 158,96 T ARS | 10,000 USD | 0,00% | 1 | 0,02 | 38,90 | 249,09 ARS | −66,41% | 2,25% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 145,94 T ARS | 7 110,000 ARS | +2,60% | 24,57 K | 0,79 | 30,29 | 234,71 ARS | +224,10% | 3,54% | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 145,94 T ARS | 6,670 USD | +2,46% | 8,43 K | 1,51 | 27,54 | 234,71 ARS | +35,96% | 3,54% | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 119,88 T ARS | 21 625,000 ARS | +0,12% | 742 | 0,59 | — | −1 078,84 ARS | −466,33% | 2,14% | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 119,88 T ARS | 21,000 USD | 0,00% | 2 | 0,04 | — | −1 078,84 ARS | −253,68% | 2,14% | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 112,85 T ARS | 25 100,000 ARS | +0,50% | 349 | 0,22 | — | −50,65 ARS | −118,38% | 1,69% | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 112,85 T ARS | 23,350 USD | +2,86% | 29 | 2,06 | — | −50,65 ARS | −107,71% | 1,69% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 111,01 T ARS | 23 900,000 ARS | +1,70% | 267 | 0,58 | 35,50 | 673,23 ARS | +275,14% | 1,94% | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 69,17 T ARS | 9 450,000 ARS | +0,96% | 2,63 K | 2,73 | 30,70 | 307,84 ARS | +49,45% | 2,76% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 69,17 T ARS | 8,800 USD | +0,57% | 8 | 0,48 | 27,70 | 307,84 ARS | −37,30% | 2,76% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 24,74 T ARS | 5 860,000 ARS | +0,17% | 103 | 0,22 | — | −689,04 ARS | −266,20% | 0,00% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 23,1 T ARS | 13 500,000 ARS | 0,00% | 898 | 0,97 | 19,41 | 695,64 ARS | +368,68% | 0,00% | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 23,1 T ARS | 13,350 USD | +5,12% | 13 | 0,47 | 18,60 | 695,64 ARS | +96,62% | 0,00% | — |
 MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORDDR | 15,88 T ARS | 2 385,000 ARS | +6,95% | 29,29 K | 0,91 | — | −262,17 ARS | −63,54% | 0,00% | — |
| MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 15,88 T ARS | 2,410 USD | 0,00% | 3 | — | — | −262,17 ARS | +31,39% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 150,2 B ARS | 1 860,000 ARS | +1,36% | 16,55 K | 0,69 | 840,11 | 2,21 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5,02 B ARS | 118,000 ARS | +1,94% | 19,64 K | 3,36 | 7,26 | 16,26 ARS | — | 0,00% | — |